Kose, B. Et Al. 2022. Investigating the compatibility, interchangeability, and clinical usability of BOT2-BF and BOT2-SF in primary school-aged children with and without developmental dyslexia. APPLIED NEUROPSYCHOLOGY-CHILD , vol.11, no.3 , 391-399.

Kose, B., KAYA KARA, Ö., Kara, K., KARABULUT, E., & ŞAHİN, S., (2022). Investigating the compatibility, interchangeability, and clinical usability of BOT2-BF and BOT2-SF in primary school-aged children with and without developmental dyslexia. APPLIED NEUROPSYCHOLOGY-CHILD , vol.11, no.3, 391-399.

Kose, Barkin Et Al. "Investigating the compatibility, interchangeability, and clinical usability of BOT2-BF and BOT2-SF in primary school-aged children with and without developmental dyslexia," APPLIED NEUROPSYCHOLOGY-CHILD , vol.11, no.3, 391-399, 2022

Kose, Barkin Et Al. "Investigating the compatibility, interchangeability, and clinical usability of BOT2-BF and BOT2-SF in primary school-aged children with and without developmental dyslexia." APPLIED NEUROPSYCHOLOGY-CHILD , vol.11, no.3, pp.391-399, 2022

Kose, B. Et Al. (2022) . "Investigating the compatibility, interchangeability, and clinical usability of BOT2-BF and BOT2-SF in primary school-aged children with and without developmental dyslexia." APPLIED NEUROPSYCHOLOGY-CHILD , vol.11, no.3, pp.391-399.

@article{article, author={Barkin Kose Et Al. }, title={Investigating the compatibility, interchangeability, and clinical usability of BOT2-BF and BOT2-SF in primary school-aged children with and without developmental dyslexia}, journal={APPLIED NEUROPSYCHOLOGY-CHILD}, year=2022, pages={391-399} }